Journal article
Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial
Abstract
We report the first long-term follow-up of a randomized trial (NCT04978259) addressing the effects of remdesivir on recovery (primary outcome) and other patient-important outcomes one year after hospitalization resulting from COVID-19. Of the 208 patients recruited from 11 Finnish hospitals, 198 survived, of whom 181 (92%) completed follow-up. At one year, self-reported recovery occurred in 85% in remdesivir and 86% in standard of care (SoC) …
Authors
Nevalainen OPO; Horstia S; Laakkonen S; Rutanen J; Mustonen JMJ; Kalliala IEJ; Ansakorpi H; Kreivi H-R; Kuutti P; Paajanen J
Journal
Nature Communications, Vol. 13, No. 1,
Publisher
Springer Nature
DOI
10.1038/s41467-022-33825-5
ISSN
2041-1723